Our own pharma editor, Brian Buntz, has won national gold in the 2023 Azbee Awards of Excellence. The accolade from the American Society of Business Publication Editors (ASBPE) recognized Buntz’s coverage for Drug Discovery & Development, which was highlighted in the sister print publication of Medical Design & Outsourcing. ASBPE is a widely recognized professional…
Landscape overview: Moderna and Pfizer lead the race in mRNA flu vaccines, with plans for regulatory filings in 2024-2025
mRNA technology helped propel the development of some of the most successful drugs in pharma history — notably, the Comirnaty COVID-19 from Pfizer/BioNTech generated almost $56 billion in 2022 while Moderna’s Spikevax vaccine raked in $18.4 billion. But demand for COVID-19 vaccines continues to cool. In 2023, Comirnaty brought in $15 billion between its two…